TrialJAMA oncology2019

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

Stéphane Oudard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.